The Patent Finder

Araris Biotech Ltd.

9 patents currently held · Updated Nov 15, 2026
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
0
Ending by 2030
Dec 2032
Next term end

When these terms end

Held patents by the year their term ends
20262027202820292030203120322033203420352036203720382039204020412042204320442045

Fee deadlines

Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
  • 1 fee due Apr 8, 2027
    The maintenance fee for Enzymatic conjugation of polypeptides (US 10,434,180) comes due Apr 8, 2027. Unpaid by Oct 8, 2027, it lapses early.
  • 1 fee due Oct 7, 2027
    The maintenance fee for Solid phase TGase-mediated conjugation of antibodies (US 10,611,824) comes due Oct 7, 2027. Unpaid by Apr 7, 2028, it lapses early.

Which patents, and when each one lapses · Pro

Recent changes

Nothing was recorded against this company's patents in the last 90 days.

Patents held now

Soonest term end first. Each date below is computed on that patent's own page, which shows the rule, the adjustments and the fee history it was derived from.

Showing 1 to 9 of 9

PatentTitleStatus Expires Confidence
US 10,675,359Enzymatic conjugation of antibodies
In force
 · From the USPTO record
In forceFrom the USPTO record
US 9,764,038Enzymatic conjugation of antibodies
In force
 · From the USPTO record
In forceFrom the USPTO record
US 9,717,803Enzymatic conjugation of polypeptides
In force
 · From the USPTO record
In forceFrom the USPTO record
US 10,132,799Screening of conjugated antibodies
In force
 · From the USPTO record
In forceFrom the USPTO record
US 10,036,010Recognition tags for TGase-mediated conjugation
In force
 · From the USPTO record
In forceFrom the USPTO record
US 9,427,478Enzymatic conjugation of polypeptides
In force
 · From the USPTO record
In forceFrom the USPTO record
US 10,071,169Enzymatic conjugation of polypeptides
In force
 · From the USPTO record
In forceFrom the USPTO record
US 10,611,824Solid phase TGase-mediated conjugation of antibodies
In force
 · From the USPTO record
In forceFrom the USPTO record
US 10,434,180Enzymatic conjugation of polypeptides
In force
 · From the USPTO record
In forceFrom the USPTO record

Sources and methods

Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand. How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 15, 2026 · includes USPTO assignment & status data published Nov 15, 2026 and grant & fee data published Nov 10, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited